Read + Share
Amedeo Smart
Independent Medical Education
Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, et al. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer 2021;162:140-146.PMID: 34808485
Email
LinkedIn
Facebook
Twitter
Privacy Policy